Johannessen Landmark C, Belkilani H, Awad L, Burns ML, Gottås A, Svendsen T, Sætre E(2026) Pharmacokinetic variability and complex two-way interactions with cenobamate in patients with refractory epilepsy Epilepsia(in press) DOI 10.1002/epi.70184, PubMed 41874535
Gervin K, Kverneland M, Nakken KO, Rudi K, Iversen PO, Landmark CJ, Selmer KK(2026) DNA methylation of antiseizure medication metabolism genes and pharmacokinetic changes in adult epilepsy patients treated with the modified Atkins diet Genes Nutr, 21(1) DOI 10.1186/s12263-026-00796-x, PubMed 41826818
Helmstaedter C, Alfstad KA, Dahl-Hansen E, Henning O, Landmark CJ, Kälviäinen R, Kyte EB, Marusic P, Mula M, Myren S, Peltola J, Rubboli G, Strzelczyk A, Jozwiak S, Lossius MI(2026) Proceedings from ERN EpiCARE "BEYOND SEIZURES" meeting, Aalesund, Norway, May the 27th. Advancing holistic care for rare and complex epilepsies in adults Epilepsy Behav, 178, 110879 DOI 10.1016/j.yebeh.2025.110879, PubMed 41719739
Get in touch
Contact information:
Jean-Paul Bernard Associate Professor II, MD, PhD. Clinical Pharmacology Ullevål Department of Pharmacology, Oslo University Hospital